These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34502108)

  • 21. Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art.
    Consiglieri G; Bernardo ME; Brunetti-Pierri N; Aiuti A
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):865-878. PubMed ID: 35773049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses.
    Muenzer J; Ho C; Lau H; Dant M; Fuller M; Boulos N; Dickson P; Ellinwood NM; Jones SA; Zanelli E; O'Neill C
    Mol Genet Metab; 2024 Aug; 142(4):108535. PubMed ID: 39018614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome editing in mucopolysaccharidoses and mucolipidoses.
    Santos HS; Poletto E; Schuh R; Matte U; Baldo G
    Prog Mol Biol Transl Sci; 2021; 182():327-351. PubMed ID: 34175047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible strategies to cross the blood-brain barrier.
    Bellettato CM; Scarpa M
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):131. PubMed ID: 30442184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy development for the mucopolysaccharidoses: Updated consensus recommendations for neuropsychological endpoints.
    van der Lee JH; Morton J; Adams HR; Clarke L; Eisengart JB; Escolar ML; Giugliani R; Harmatz P; Hogan M; Kearney S; Muenzer J; Muschol N; Rust S; Saville BR; Semrud-Clikeman M; Wang R; Shapiro E
    Mol Genet Metab; 2020; 131(1-2):181-196. PubMed ID: 32917509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Principles of therapeutic approaches for mucopolysaccharidoses].
    Caillaud C
    Arch Pediatr; 2014 Jun; 21 Suppl 1():S39-45. PubMed ID: 25063383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme replacement therapy: efficacy and limitations.
    Concolino D; Deodato F; Parini R
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):120. PubMed ID: 30442189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?
    Tomatsu S; Azario I; Sawamoto K; Pievani AS; Biondi A; Serafini M
    J Inherit Metab Dis; 2016 Mar; 39(2):189-202. PubMed ID: 26578156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.
    Barone R; Pellico A; Pittalà A; Gasperini S
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):121. PubMed ID: 30442188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of murine mucopolysaccharidosis type IIIA central nervous system pathology by intracerebroventricular lentiviral-mediated gene delivery.
    McIntyre C; Derrick-Roberts AL; Byers S; Anson DS
    J Gene Med; 2014; 16(11-12):374-87. PubMed ID: 25418946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New treatments for the mucopolysaccharidoses: from pathophysiology to therapy.
    Fecarotta S; Gasperini S; Parenti G
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):124. PubMed ID: 30442204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].
    Giugliani R; Federhen A; Muñoz Rojas MV; Vieira TA; Artigalás O; Pinto LL; Azevedo AC; Acosta AX; Bomfim C; Lourenço CM; Kim CA; Horovitz D; Souza DB; Norato D; Marinho D; Palhares D; Santos ES; Ribeiro E; Valadares ER; Guarany F; De Lucca GR; Pimentel H; Souza IN; Corrêa Neto J; Fraga JC; Góes JE; Cabral JM; Simeonato J; Llerena JC; Jardim LB; Giuliani Lde R; Silva LC; Santos M; Moreira MA; Kerstenetzky M; Ribeiro M; Ruas N; Barrios P; Aranda P; Honjo R; Boy R; Costa R; Souza CF; Alcântara FF; Avilla SG; Fagondes S; Martins AM
    Rev Assoc Med Bras (1992); 2010; 56(3):271-7. PubMed ID: 20676532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current and Emerging Therapies for Mucopolysaccharidoses.
    Lagler FB
    Handb Exp Pharmacol; 2020; 261():39-56. PubMed ID: 31451968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications.
    Pierzynowska K; Gaffke L; Cyske Z; Węgrzyn G; Buttari B; Profumo E; Saso L
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-Based Approaches to Inherited Neurometabolic Diseases.
    Poletti V; Biffi A
    Hum Gene Ther; 2019 Oct; 30(10):1222-1235. PubMed ID: 31397176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Neuronopathic Mucopolysaccharidoses with Blood-Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis.
    Sonoda H; Takahashi K; Minami K; Hirato T; Yamamoto T; So S; Tanizawa K; Schmidt M; Sato Y
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapies for the bone in mucopolysaccharidoses.
    Tomatsu S; Alméciga-Díaz CJ; Montaño AM; Yabe H; Tanaka A; Dung VC; Giugliani R; Kubaski F; Mason RW; Yasuda E; Sawamoto K; Mackenzie W; Suzuki Y; Orii KE; Barrera LA; Sly WS; Orii T
    Mol Genet Metab; 2015 Feb; 114(2):94-109. PubMed ID: 25537451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrate reduction therapies for mucopolysaccharidoses.
    Jakóbkiewicz-Banecka J; Piotrowska E; Gabig-Cimińska M; Borysiewicz E; Słomińska-Wojewódzka M; Narajczyk M; Węgrzyn A; Węgrzyn G
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1860-5. PubMed ID: 21902626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapies for neurological disease in the mucopolysaccharidoses.
    Anson DS; McIntyre C; Byers S
    Curr Gene Ther; 2011 Apr; 11(2):132-43. PubMed ID: 21291356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different serum enzyme levels are required to rescue the various systemic features of the mucopolysaccharidoses.
    Cotugno G; Tessitore A; Capalbo A; Annunziata P; Strisciuglio C; Faella A; Aurilio M; Di Tommaso M; Russo F; Mancini A; De Leonibus E; Aloj L; Auricchio A
    Hum Gene Ther; 2010 May; 21(5):555-69. PubMed ID: 20021231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.